Vincerx Pharma (VINC) Earnings Date, Estimates & Call Transcripts $0.40 +0.02 (+5.29%) (As of 10/16/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 12EstimatedActual EPS (Aug. 8) -$0.05 Beat By $0.12 Consensus EPS (Aug. 8) -$0.17 Get Vincerx Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for VINC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVINC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VINC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, it's such a radical departure from what most people think of when it comes to typical income strategies, I'm calling it: The Perfect Income AltcoinClick here to get access to my 'Perfect Income Altcoin' for just $3 today. Vincerx Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.26)($0.26)($0.26)Q2 20241($0.17)($0.17)($0.17)Q3 20241($0.14)($0.14)($0.14)Q4 20241($0.08)($0.08)($0.08)FY 20244($0.65)($0.65)($0.65)VINC Earnings Date and InformationVincerx Pharma last released its earnings data on August 8th, 2024. The reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.12. Vincerx Pharma has generated ($1.79) earnings per share over the last year (($1.79) diluted earnings per share). Earnings for Vincerx Pharma are expected to grow in the coming year, from ($0.38) to ($0.23) per share. Vincerx Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.Read More Vincerx Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Estimated)------- 8/8/2024-($0.17)($0.05)+$0.12($0.05)--5/14/2024Q1 2024($0.26)($0.34)($0.08)($0.10)--3/29/2024Q4 2023-($0.23)($0.23)($0.23)--11/14/2023Q3 2023($0.49)($0.46)+$0.03($0.46)--8/7/2023Q2 2023($0.65)($0.52)+$0.13($0.52)--5/11/2023Q1 2023($0.69)($0.68)+$0.01($0.68)--A Totally New ‘Income Coin’ (Ad)Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, it's such a radical departure from what most people think of when it comes to typical income strategies, I'm calling it: The Perfect Income AltcoinClick here to get access to my 'Perfect Income Altcoin' for just $3 today.3/28/2023Q4 2022($0.63)($0.65)($0.02)($0.65)--11/10/2022Q3 2022($0.80)($0.80)-($0.80)--8/11/2022Q2 2022($0.92)($0.88)+$0.04($0.88)--5/12/2022Q1 2022($0.87)($0.79)+$0.08($0.79)--3/29/2022Q4 2021($0.93)($0.85)+$0.08($1.39)--11/12/2021Q3 2021($0.79)($1.02)($0.23)($0.65)--8/12/2021Q2 2021($0.30)($0.12)+$0.18($0.12)--5/16/2021Q1 2021($0.32)($0.46)($0.14)($0.46)-- Vincerx Pharma Earnings - Frequently Asked Questions When is Vincerx Pharma's earnings date? Vincerx Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on VINC's earnings history. Did Vincerx Pharma beat their earnings estimates last quarter? In the previous quarter, Vincerx Pharma (NASDAQ:VINC) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.12. Learn more on analysts' earnings estimate vs. VINC's actual earnings. How much profit does Vincerx Pharma generate each year? Vincerx Pharma (NASDAQ:VINC) has a recorded net income of -$40.16 million. VINC has generated -$1.79 earnings per share over the last four quarters. What is Vincerx Pharma's EPS forecast for next year? Vincerx Pharma's earnings are expected to grow from ($0.38) per share to ($0.23) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Affimed Earnings Results Aadi Bioscience Earnings Results Barinthus Biotherapeutics Earnings Results Vor Biopharma Earnings Results Evoke Pharma Earnings Results Rallybio Earnings Results Celularity Earnings Results ProPhase Labs Earnings Results vTv Therapeutics Earnings Results TC Biopharm Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Bank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 Earnings This page (NASDAQ:VINC) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thEarnings Season: Your FREE Ticket to Trading Success Don't just survive earnings season - learn how to pote...StockEarnings | SponsoredThe Standard Oil of AI?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
